Anticancer and Anti‐Inflammatory Potential of Coptisine as a Planar Quaternary Benzo[C]Phenanthridine Alkaloid With G‐Quadruplex DNA Telomeric Induction Activity
- 2 May 2025
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 86 (3) , e70071
Abstract
Coptisine, an isoquinoline‐based phytochemical, exhibits a broad spectrum of biological activities, including anticancer and anti‐inflammatory properties. Its planar chemical structure allows for the induction of anticancer effects by forming telomeric G‐quadruplex structures. Despite its promising medicinal benefits, the clinical utilization of this compound is limited by critical shortcomings such as low efficacy and poor pharmacokinetics. While in vitro studies demonstrate high cytotoxicity, in vivo research highlights its favorable toxicity profile, attributed to the conversion of its iminium form to a less toxic alkanolamine form within the physiological setting. Past endeavors have focused on rectifying these limitations through structural modifications to yield more efficacious molecules. In the current review, we provide an overview of the anti‐inflammatory and anticancer properties of coptisine and its semisynthetic derivatives, in conjunction with its pharmacokinetic profile, synthesis, and safety/toxicity considerations. This review draws upon information sourced from publications indexed in esteemed scientific databases like Web of Science, PubMed, and Scopus, among others. To prepare each section, we utilized Coptisine and section‐specific keywords, emphasizing recent literature findings (2014–2024) while maintaining a broad scope due to the study's nature. In conclusion, this review underscores coptisine's remarkable anticancer and anti‐inflammatory properties, suggesting that further exploration of structural modifications may yield semisynthetic derivatives with enhanced safety/toxicity profiles, pharmacokinetics, and therapeutic potential.Keywords
This publication has 134 references indexed in Scilit:
- Screening of differential components of Gegenqinlian decoction and their comparative pharmacokinetics in normal and pyrexia rats using UHPLC‐FT‐ICR‐MS and UHPLC–MS/MSBiomedical Chromatography, 2021
- Selectivity and Targeting of G‐Quadruplex Binders Activated by Adaptive Binding and Controlled by Chemical KineticsAngewandte Chemie International Edition, 2021
- Pharmacokinetics and tissue distribution of four major bioactive components in rats after oral administration of Xianglian pillBiomedical Chromatography, 2019
- Simultaneous determination of six coptis alkaloids in urine and feces by LC–MS/MS and its application to excretion kinetics and the compatibility mechanism of Jiao‐Tai‐Wan in insomniac ratsBiomedical Chromatography, 2018
- Simultaneous determination of baicalin, baicalein, wogonoside, wogonin, scutellarin, berberine, coptisine, ginsenoside Rb1 and ginsenoside Re of Banxia xiexin decoction in rat plasma by LC–MS/MS and its application to a pharmacokinetic studyBiomedical Chromatography, 2017
- Pharmacokinetics and tissue distribution of coptisine in rats after oral administration by liquid chromatography–mass spectrometryBiomedical Chromatography, 2017
- A General, Concise Strategy that Enables Collective Total Syntheses of over 50 Protoberberine and Five Aporhoeadane Alkaloids within Four to Eight StepsChemistry – A European Journal, 2016
- Recognition of human telomeric G‐quadruplex DNA by berberine analogs: effect of substitution at the 9 and 13 positions of the isoquinoline moietyJournal of Molecular Recognition, 2015
- Formation of Human Telomeric G‐quadruplex Structures Induced by the Quaternary Benzophenanthridine Alkaloids: Sanguinarine, Nitidine, and ChelerythrineChinese Journal of Chemistry, 2010
- Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectivesMedicinal Research Reviews, 2006